Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)

Bruce R. Blazar, Daniel J. Weisdorf, Todd DeFor, Anne Goldman, Thomas Braun, Samuel Silver, James L M Ferrara

Research output: Contribution to journal › Article › peer-review

136 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds